Clinical outcome of wild-type AmpC-producing Enterobacterales infection in critically ill patients treated with β-lactams: a prospective multicenter study

Abstract Background β-lactams are the main antibiotics used against wild-type AmpC-producing Enterobacterales (wtAE). However, they may fail or select AmpC-overproducing mutants. Our aim was to assess factors associated with clinical failure of β-lactams in the treatment of wtAE infection. Methods F...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Roman Mounier, Ronan Le Guen, Paul-Louis Woerther, Mathieu Nacher, Clément Bonnefon, Nicolas Mongardon, Olivier Langeron, Eric Levesque, Séverine Couffin, Stéphanie Houcke, Michel Wolff, Ariane Roujansky, Caroline Schimpf, Armand Mekontso Dessap, Fabrice Cook, Keyvan Razazi, Hatem Kallel
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2022-11-01
Serie:	Annals of Intensive Care
Soggetti:	AmpC-producing Enterobacterales AmpC β-lactamases Third-generation cephalosporins Infection ICU
Accesso online:	https://doi.org/10.1186/s13613-022-01079-5
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!